February 3, 2006

FOR RELEASE:  Immediately

CTS EMS Establishes Microelectronic Assembly Capability in North America
 

Elkhart, IN…CTS Corporation (NYSE: CTS) today announced its Electronics Manufacturing Solutions (EMS) business is expanding its support for high-technology industries by establishing a Class 10,000 cleanroom environment and wire bonding capability at its Moorpark, California headquarters. This capability will enable the processing of bare die through complete assembly and test for products that require miniaturized assembly technologies. The investment is part of CTS’ ongoing commitment to extending the range of products and services available in North America.  

The additional capability complements existing processes and services offered by CTS to its customers in the defense, aerospace and medical sectors, whose critical product applications require miniature, high-reliability, highly complex product assemblies. The cleanroom environment and wire bonding services are important in CTS’ commitment to providing customers with a “one-stop-shop” for high quality mixed-technology, hybrid microelectronic assemblies.

Don Schroeder, President of the EMS Business, stated, “From design to direct ship, CTS’ objective is to deliver a full turnkey manufacturing solution across all of our strategic markets. This additional capability further complements the specialized manufacturing services we deliver to customers who require very high quality, high reliability product.”  
 

About CTS EMS
CTS EMS is a Tier Two provider of electronics manufacturing products and services to a range of markets, including communications, defense and aerospace, medical and industrial equipment.  With headquarters in Moorpark, California, CTS operates seven manufacturing facilities worldwide, in Europe, North America and Asia.
 

About CTS
CTS is a leading designer and manufacturer of electronic components and sensors and a provider of electronics manufacturing services (EMS) to OEMs in the automotive, computer, communications, medical and industrial markets. CTS manufactures products in North America, Europe and Asia. CTS' stock is traded on the NYSE under the ticker symbol "CTS.” 
 

Safe Harbor Statement
This press release contains certain statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include, but are not limited to, any financial or other guidance, and all statements that are not based on historical fact, but rather reflect our current expectations concerning future results and events.  We make certain assumptions when making forward-looking statements, any of which could prove inaccurate, including, but not limited to, statements about our future operating results and business plans.  The ultimate correctness of these forward-looking statements is dependent upon a number of known and unknown risks and events, and is subject to various uncertainties and other factors that may cause our actual results, performance, or achievements to be different from any future results, performance, or achievements expressed or implied by these statements.

For more detailed information on the risks and uncertainties associated with CTS' business activities, see our reports filed with the SEC.  CTS undertakes no obligation to publicly update its forward-looking statements, whether as a result of market or industry changes, new information or future events.